Controlling the Biomimetic Implant Interface: Modulating Antimicrobial Activity by Spacer Design

Area of Science:

• Biomaterials Science
• Infectious Disease Research
• Surface Chemistry

Background:

• Surgical site infections (SSIs) are a major cause of post-operative complications, including implant loosening and revision surgeries.
• The implant surface and its interaction with host cells and microbes are critical in preventing SSIs.
• Current strategies often fail to address both infection prevention and host integration simultaneously.

Purpose of the Study:

• To engineer a biomimetic interface on titanium implants using a chimeric peptide.
• To impart antimicrobial properties and enhance host cell interaction at the implant surface.
• To investigate the role of the spacer domain in optimizing the chimeric peptide's efficacy.

Main Methods:

• Designed a chimeric peptide combining a titanium-binding peptide (TiBP) and an antimicrobial peptide (AMP).
• Investigated different spacer designs between the TiBP and AMP domains to optimize antimicrobial activity.
• Coated titanium surfaces with the chimeric peptide and evaluated bacterial adhesion (S. mutans, S. epidermidis) and host cell responses.

Main Results:

• Optimized chimeric peptide design improved minimum inhibitory concentration (MIC) threefold against S. mutans.
• Chimeric peptide-coated surfaces showed significant bacterial reduction: ninefold for S. mutans and 48-fold for S. epidermidis.
• Enhanced host cell attachment and viability were observed on the biomimetic interface compared to untreated surfaces.

Conclusions:

• The developed chimeric peptide creates effective biomimetic interfaces on titanium, reducing bacterial load and promoting host cell integration.
• This peptide-based approach offers a promising strategy for developing next-generation implantable materials with improved safety and efficacy.
• The methodology can be extended to functionalize various biomaterial surfaces for diverse clinical applications.